Benchmarking Ageing Biomarkers Against Plasma Proteomic Signatures
This study evaluates multimodal ageing biomarkers and plasma proteomic signatures in relation to all-cause mortality, providing insights into biological aging and mortality risk.
This study evaluates multimodal ageing biomarkers and plasma proteomic signatures in relation to all-cause mortality, providing insights into biological aging and mortality risk.
This study explores how blood cell composition affects DNA methylation age and age acceleration, revealing distinct biological interpretations and modest associations with health outcomes.
This study benchmarks proteomic organ clocks against established ageing biomarkers and identifies plasma proteins associated with all-cause mortality in a cohort of older adults.
This study explores how blood cell composition affects DNA methylation age and age acceleration, revealing distinct biological interpretations and modest impacts on health outcomes.
This study explores how blood cell composition influences DNA methylation age and age acceleration, revealing distinct biological interpretations.
This study benchmarks proteomic organ clocks against established ageing biomarkers to explore their association with all-cause mortality in a cohort of older adults.
This study explores how blood cell composition affects DNA methylation age and age acceleration, revealing distinct biological interpretations and modest impacts on health outcomes.
This study benchmarks proteomic organ clocks against established ageing biomarkers to explore their associations with all-cause mortality in a cohort of older adults.
This research benchmarks proteomic organ clocks against established ageing biomarkers to explore their associations with all-cause mortality over 16 years.
A randomized controlled trial evaluates a web-based tool’s impact on health behaviors when integrated into certified exercise practitioner services.